| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.93B | +9.4% |
| R&D Expense | $83.1M | +13.2% |
| SG&A Expense | $705.3M | +5.7% |
| Operating Income | $1.44B | +24.1% |
| Pre-tax Income | $1.27B | +35.0% |
| Income Tax | $302.9M | +255.9% |
| Net Income | $963.9M | +14.4% |
| EPS (Basic) | $2.34 | +19.4% |
| EPS (Diluted) | $2.30 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.03B | -10.9% |
| Accounts Receivable | $1.13B | -14.4% |
| Inventory | $1.15B | +7.1% |
| Current Assets | $5.55B | +1.4% |
| Total Assets | $10.12B | +2.5% |
| Current Liabilities | $4.91B | +1.0% |
| Long-term Debt | $430.0M | -51.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.76B | +83.6% |
| Capital Expenditures | $317.2M | +12.6% |
| Investing Cash Flow | -$298.3M | -293.5% |
| Financing Cash Flow | -$1.62B | -150.1% |
| Free Cash Flow | $1.45B | +113.0% |
| +20.4% |
| Total Liabilities |
| $6.71B |
| -0.3% |
| Stockholders' Equity | $3.36B | +8.7% |